IDEAS home Printed from https://ideas.repec.org/a/plo/pone00/0125165.html
   My bibliography  Save this article

Public Opinions about Overdiagnosis: A National Community Survey

Author

Listed:
  • Ray Moynihan
  • Brooke Nickel
  • Jolyn Hersch
  • Elaine Beller
  • Jenny Doust
  • Shane Compton
  • Alexandra Barratt
  • Lisa Bero
  • Kirsten McCaffery

Abstract

Background: Despite evidence about the "modern epidemic" of overdiagnosis, and expanding disease definitions that medicalize more people, data are lacking on public views about these issues. Our objective was to measure public perceptions about overdiagnosis and views about financial ties of panels setting disease definitions. Methods: We conducted a 15 minute Computer Assisted Telephone Interview with a randomly selected community sample of 500 Australians in January 2014. We iteratively developed and piloted a questionnaire, with a convenience sample (n=20), then with participants recruited by a research company (n=20). Questions included whether respondents had been informed about overdiagnosis; opinions on informing people; and views about financial ties among panels writing disease definitions. Findings: Our sample was generally representative, but included a higher proportion of females and seniors, typical of similar surveys. American Association for Public Opinion Research response rate was 20% and cooperation rate was 44%. Only 10% (95% CI 8%–13%) of people reported ever being told about overdiagnosis by a doctor. 18% (95% CI 11%–28%) of men who reported having prostate cancer screening, and 10% (95% CI 6%–15%) of women who reported having mammography said they were told about overdiagnosis. 93% (95% CI 90%–95%) agreed along with screening benefits, people should be informed about overdiagnosis. On panels setting disease definitions, 78% (95% CI 74%–82%) felt ties to pharmaceutical companies inappropriate, and 91% (95% CI 82%–100%) believed panels should have a minority or no members with ties. Limitations included questionnaire novelty and complexity. Conclusions: A small minority of Australians surveyed, including those reporting being screened for prostate or breast cancer, reported being informed of overdiagnosis; most believed people should be informed; and a majority felt it inappropriate that doctors with ties to pharmaceutical companies write disease definitions. Results suggest strategies to better inform people about overdiagnosis, and review disease definition processes, have significant public sympathy.

Suggested Citation

  • Ray Moynihan & Brooke Nickel & Jolyn Hersch & Elaine Beller & Jenny Doust & Shane Compton & Alexandra Barratt & Lisa Bero & Kirsten McCaffery, 2015. "Public Opinions about Overdiagnosis: A National Community Survey," PLOS ONE, Public Library of Science, vol. 10(5), pages 1-13, May.
  • Handle: RePEc:plo:pone00:0125165
    DOI: 10.1371/journal.pone.0125165
    as

    Download full text from publisher

    File URL: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0125165
    Download Restriction: no

    File URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0125165&type=printable
    Download Restriction: no

    File URL: https://libkey.io/10.1371/journal.pone.0125165?utm_source=ideas
    LibKey link: if access is restricted and if your library uses this service, LibKey will redirect you to where you can use your library subscription to access this item
    ---><---

    References listed on IDEAS

    as
    1. Amanda Wilson & Billie Bonevski & Alison Jones & David Henry, 2009. "Media Reporting of Health Interventions: Signs of Improvement, but Major Problems Persist," PLOS ONE, Public Library of Science, vol. 4(3), pages 1-5, March.
    2. Raymond N Moynihan & Georga P E Cooke & Jenny A Doust & Lisa Bero & Suzanne Hill & Paul P Glasziou, 2013. "Expanding Disease Definitions in Guidelines and Expert Panel Ties to Industry: A Cross-sectional Study of Common Conditions in the United States," PLOS Medicine, Public Library of Science, vol. 10(8), pages 1-12, August.
    3. Holbrook, Anne & Lexchin, Joel & Pullenayegum, Eleanor & Campbell, Craig & Marlow, Bernard & Troyan, Sue & Weijer, Charles & Blackmer, Jeff & Brazil, Kevin & Willison, Don, 2013. "What do Canadians think about physician–pharmaceutical industry interactions?," Health Policy, Elsevier, vol. 112(3), pages 255-263.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Anne Stiggelbout & Tessa Copp & Gemma Jacklyn & Jesse Jansen & Gerrit-Jan Liefers & Kirsten McCaffery & Jolyn Hersch, 2020. "Women’s Acceptance of Overdetection in Breast Cancer Screening: Can We Assess Harm-Benefit Tradeoffs?," Medical Decision Making, , vol. 40(1), pages 42-51, January.
    2. Rozbroj, Tomas & Haas, Romi & O'Connor, Denise & Carter, Stacy M. & McCaffery, Kirsten & Thomas, Rae & Donovan, Jan & Buchbinder, Rachelle, 2021. "How do people understand overtesting and overdiagnosis? Systematic review and meta-synthesis of qualitative research," Social Science & Medicine, Elsevier, vol. 285(C).

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Fadi El-Jardali & Lama Bou Karroum & Lamya Bawab & Ola Kdouh & Farah El-Sayed & Hala Rachidi & Malak Makki, 2015. "Health Reporting in Print Media in Lebanon: Evidence, Quality and Role in Informing Policymaking," PLOS ONE, Public Library of Science, vol. 10(8), pages 1-19, August.
    2. Unruh, Lynn & Rice, Thomas & Rosenau, Pauline Vaillancourt & Barnes, Andrew J., 2016. "The 2013 cholesterol guideline controversy: Would better evidence prevent pharmaceuticalization?," Health Policy, Elsevier, vol. 120(7), pages 797-808.
    3. Joseph W Taylor & Marie Long & Elizabeth Ashley & Alex Denning & Beatrice Gout & Kayleigh Hansen & Thomas Huws & Leifa Jennings & Sinead Quinn & Patrick Sarkies & Alex Wojtowicz & Philip M Newton, 2015. "When Medical News Comes from Press Releases—A Case Study of Pancreatic Cancer and Processed Meat," PLOS ONE, Public Library of Science, vol. 10(6), pages 1-13, June.
    4. Atiqur sm-Rahman & Chih Hung Lo & Yasmin Jahan, 2021. "Dementia in Media Coverage: A Comparative Analysis of Two Online Newspapers across Time," IJERPH, MDPI, vol. 18(19), pages 1-19, October.
    5. Anju Murayama & Yuki Senoo & Kayo Harada & Yasuhiro Kotera & Hiroaki Saito & Toyoaki Sawano & Yosuke Suzuki & Tetsuya Tanimoto & Akihiko Ozaki, 2022. "Awareness and Perceptions among Members of a Japanese Cancer Patient Advocacy Group Concerning the Financial Relationships between the Pharmaceutical Industry and Physicians," IJERPH, MDPI, vol. 19(6), pages 1-24, March.
    6. Racha Fadlallah & Hala Nas & Dana Naamani & Fadi El-Jardali & Ihsan Hammoura & Lina Al-Khaled & Hneine Brax & Lara Kahale & Elie A Akl, 2016. "Knowledge, Beliefs and Attitudes of Patients and the General Public towards the Interactions of Physicians with the Pharmaceutical and the Device Industry: A Systematic Review," PLOS ONE, Public Library of Science, vol. 11(8), pages 1-34, August.
    7. Kwamena Kwansah-Aidoo & Virginia Mapedzahama, 2015. "Media Event, Racial Ramblings, or Both? An Analysis of Media Coverage of the Tamworth Council Sudanese Refugees Resettlement Case (2006)," SAGE Open, , vol. 5(4), pages 21582440156, December.
    8. Moriarty, Frank & Larkin, James & Fahey, Tom, 2021. "Payments reported by the pharmaceutical industry in Ireland from 2015 to 2019: An observational study," Health Policy, Elsevier, vol. 125(10), pages 1297-1304.
    9. Cristina Morciano & Vittorio Basevi & Carla Faralli & Michele Hilton Boon & Sabina Tonon & Domenica Taruscio, 2016. "Policies on Conflicts of Interest in Health Care Guideline Development: A Cross-Sectional Analysis," PLOS ONE, Public Library of Science, vol. 11(11), pages 1-24, November.

    More about this item

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0125165. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.